Niraparib Tosylate

Niraparib tosylate is an antineoplastic agent.

General

Niraparib tosylate is available in the following dosage form(s) and strength(s):

Capsules: 100 mg1

Dosage

It is essential that the manufacturer's labeling be consulted for more detailed information on dosage and administration of this drug. Dosage summary:

• Recommended dose is 300 mg taken once daily with or without food.1

• Continue treatment until disease progression or unacceptable adverse reaction.1

• For adverse reactions, consider interruption of treatment, dose reduction, or dose discontinuation.1

Specific Drugs

It is essential that the manufacturer's labeling be consulted for more detailed information on interactions with this drug, including possible dosage adjustments. Interaction highlights:

Please see product labeling for drug interaction information.

AHFS First Release. For additional information until a more detailed monograph is developed and published, the manufacturer's labeling should be consulted. It is essential that the manufacturer's labeling be consulted for more detailed information on usual uses, dosage and administration, cautions, precautions, contraindications, potential drug interactions, laboratory test interferences, and acute toxicity.